Case number 1:24-cv-01345
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 6, 2025 | N/A | Case associated with lead case: Create association to 1:23-cv-00152-JLH. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 1:23-cv-152-JLH ONLY. (ceg) (Entered: 05/06/2025) (0) |
| May 6, 2025 | 21 | SO ORDERED, re (177 in 1:23-cv-00152-JLH, 20 in 1:24-cv-01345-JLH) Stipulation and Order to Consolidate. C.A. No. 24-1345-JLH will be consolidated into C.A. No. 23-152-JLH for all purposes and all papers will be filed in C.A. No. 23-152-JLH. (*Reset Scheduling Order Deadlines: Fact Discovery completed by 9/19/2025; Expert Discovery due by 1/9/2026; Interim Status Report due by 7/22/2025; Dispositive and Daubert Motions due by 1/23/2026; Answering Brief due 2/13/2026; Reply Brief due 2/27/2026; A Motion Hearing is set for 3/20/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall; Joint Status Report regarding First Trial due by 4/15/2026; Proposed Pretrial Order due by 7/20/2026; A Pretrial Conference is set for 7/27/2026 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall; A 4-day Jury Trial is set for 8/3/2026 at 09:00 AM in Courtroom 6D before Judge Jennifer L. Hall; See Order for complete details). Signed by Judge Jennifer L. Hall on 5/6/2025. Associated Cases: 1:23-cv-00152-JLH, 1:24-cv-01345-JLH(ceg) Modified on 5/6/2025 (ceg). (Entered: 05/06/2025) (4) |
| Apr 30, 2025 | 20 | STIPULATION and [Proposed] Order to Consolidate Actions by Vanda Pharmaceuticals Inc.. (Joyce, Alexandra) (Entered: 04/30/2025) (4) |
| Apr 23, 2025 | N/A | SO ORDERED, re 19 Stipulation and Order to Extend the deadline for the parties to submit a proposed Scheduling Order and joint letter to April 30, 2025. Ordered by Judge Jennifer L. Hall on 4/23/2025. (ceg) (Entered: 04/23/2025) (0) |
| Apr 23, 2025 | 19 | STIPULATION TO EXTEND TIME the deadline for the parties to submit (i) a proposed Scheduling Order; and (ii) a joint letter setting forth (a) a description of the case; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference to April 30, 2025 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 04/23/2025) (2) |
| Apr 4, 2025 | N/A | SO ORDERED, re 18 Stipulation and Order to Extend (1) the deadline for Plaintiff to answer, move or otherwise respond to Defendant's Answer and Counterclaims (D.I. 13 ) and (2) the deadline for Plaintiff to submit its answering brief in opposition to Defendant's Partial Motion to Dismiss (D.I. 11 ). (*Reset Answer Deadlines: Vanda Pharmaceuticals Inc. answer due 5/12/2025; *Reset Briefing Schedule re 11 Partial to Dismiss for Failure to State a Claim: Answering Brief due 5/12/2025). Ordered by Judge Jennifer L. Hall on 4/4/2025. (ceg) (Entered: 04/04/2025) (0) |
| Apr 3, 2025 | 18 | STIPULATION TO EXTEND TIME (1) the Deadline for Plaintiff to answer, move or otherwise respond to Defendant's Answer and Counterclaims (D.I. 13) and (2) the Deadline for Plaintiff to submit its answering brief in opposition to Defendant's Partial Motion to Dismiss Under Rule 12(b)(6) (D.I. 11) to May 12, 2025 - filed by Vanda Pharmaceuticals Inc.. (Silver, Daniel) (Entered: 04/03/2025) (2) |
| Mar 25, 2025 | N/A | Pro Hac Vice Attorney Sarah P. Hogarth, Paul W. Hughes, Mary H. Schnoor for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(cdd) (Entered: 03/25/2025) (0) |
| Mar 25, 2025 | N/A | Pro Hac Vice Attorney Paul W. Hughes, Jason A. Leonard for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(cdd) (Entered: 03/25/2025) (0) |
| Mar 25, 2025 | N/A | Pro Hac Vice Attorney Samoneh Kadivar Schickel for Vanda Pharmaceuticals Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(cdd) (Entered: 03/25/2025) (0) |
| Mar 24, 2025 | 13 | ANSWER to 6 Amended Complaint [Defendant Teva's Answer and Counterclaims], COUNTERCLAIM against Vanda Pharmaceuticals Inc., by Teva Pharmaceuticals USA, Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20)(Hoeschen, Nathan) Modified on 3/24/2025 (ceg). (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 11 | MOTION to Dismiss for Failure to State a Claim [Teva Pharmaceuticals USA, Inc.'s Partial Motion to Dismiss Under Rule 12(b)(6) - filed by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Hoeschen, Nathan) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 12 | OPENING BRIEF in Support re 11 MOTION to Dismiss for Failure to State a Claim [Teva Pharmaceuticals USA, Inc.'s Partial Motion to Dismiss Under Rule 12(b)(6) filed by Teva Pharmaceuticals USA, Inc..Answering Brief/Response due date per Local Rules is 4/7/2025. (Hoeschen, Nathan) (Entered: 03/24/2025) (20) |
| Mar 24, 2025 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm - filed by Vanda Pharmaceuticals Inc.. (Attachments: # 1 Certifications for Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm)(Silver, Daniel) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 15 | Pro Hac Vice Fee - Credit Card Payment received for Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, and Samoneh Kadivar Schickel. ( re 14 MOTION for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm )( Payment of $ 250, receipt number ADEDC-4644149).(Silver, Daniel) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 16 | Pro Hac Vice Fee - Credit Card Payment received for Connor Romm. ( re 14 MOTION for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm )( Payment of $ 50, receipt number ADEDC-4644154).(Silver, Daniel) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | N/A | SO ORDERED, re (13 in 1:24-cv-01344-JLH, 14 in 1:24-cv-01345-JLH) Motion for Pro Hac Vice Appearance of Attorney Paul W. Hughes, Sarah P. Hogarth, Jason Leonard, Mary Schnoor, Samoneh Kadivar Schickel, and Connor Romm filed by Vanda Pharmaceuticals Inc. Ordered by Judge Jennifer L. Hall on 3/24/2025. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH(ceg) (Entered: 03/24/2025) (0) |
| Mar 24, 2025 | 17 | ORAL ORDER: IT IS HEREBY ORDERED that, within thirty days, the parties shall jointly prepare and file the following: (i) a proposed Scheduling Order consistent with Judge Hall's "Rule 16 Scheduling Order - Patent", and (ii) a letter, not to exceed three pages, setting forth (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order; and (c) a list of any other issues the parties want to address at the Rule 16 Scheduling Conference. Thereafter, the Court may schedule a Rule 16 Scheduling Conference to be held with Judge Hall. The Scheduling Order can be found on Judge Hall's portion of the District Court's website. Ordered by Judge Jennifer L. Hall on 3/24/2025. (ceg) (Entered: 03/24/2025) (0) |
| Mar 14, 2025 | 10 | STIPULATION TO EXTEND TIME to move, plead, or otherwise respond to the First Amended Complaint to March 24, 2025 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 03/14/2025) (1) |
| Mar 14, 2025 | N/A | SO ORDERED, re 10 Stipulation and Order to Extend Time to move, plead, or otherwise respond to the First Amended Complaint to March 24, 2025. (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 3/24/2025). Ordered by Judge Jennifer L. Hall on 3/14/2025. (ceg) (Entered: 03/14/2025) (0) |
| Jan 29, 2025 | N/A | SO ORDERED, re 8 Stipulation and Order to Extend Time for Defendant Teva Pharmaceuticals USA, Inc. to move, plead, or otherwise respond to the Complaint to March 17, 2025. (*Reset Answer Deadlines: Teva Pharmaceuticals USA, Inc. answer due 3/17/2025). Ordered by Judge Jennifer L. Hall on 1/29/2025. (ceg) (Entered: 01/29/2025) (0) |
| Jan 29, 2025 | 9 | Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd for Teva Pharmaceuticals USA, Inc. filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 01/29/2025) (1) |
| Jan 29, 2025 | 8 | STIPULATION TO EXTEND TIME for Defendant Teva Pharmaceuticals USA, Inc. to move, plead, or otherwise respond to the Complaint to March 17, 2025 - filed by Teva Pharmaceuticals USA, Inc.. (Hoeschen, Nathan) (Entered: 01/29/2025) (1) |
| Jan 24, 2025 | 7 | SUMMONS Returned Executed by Vanda Pharmaceuticals Inc..Teva Pharmaceuticals USA, Inc. served on 1/24/2025, answer due 2/14/2025. (Joyce, Alexandra) (Entered: 01/24/2025) (2) |
| Jan 23, 2025 | 6 | Amended Complaint* (1) |
| Dec 11, 2024 | N/A | Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:24-cv-01344-JLH, 1:24-cv-01345-JLH (rjb) (Entered: 12/11/2024) (0) |
| Dec 9, 2024 | 5 | Summons Issued as to Teva Pharmaceuticals USA, Inc. on 12/9/2024. (mpb) (Entered: 12/10/2024) (2) |
| Dec 9, 2024 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Black Rock Fund Advisors for Vanda Pharmaceuticals Inc. filed by Vanda Pharmaceuticals Inc. (mpb) (Entered: 12/10/2024) (1) |
| Dec 9, 2024 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,918,556. (mpb) (Entered: 12/10/2024) (1) |
| Dec 9, 2024 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) (Entered: 12/10/2024) (3) |
| Dec 9, 2024 | 1 | Complaint* (1) |
